by Nassir Ghaemi | Aug 16, 2025
A psychiatrist pulls back the curtain on psychedelics, exposing hype, weak data, and hidden conflicts of interest. Dr. Daniel Heringer, a psychiatry resident in Cleveland, sits down with mentor Dr. Nassir Ghaemi to clarify terminology—why “hallucinogen” is the...
by Nassir Ghaemi | Aug 16, 2025
What really counts as trauma? Dr. Nassir Ghaemi untangles PTSD, combat, sexual abuse and the myth of “complex trauma”. In this live‑stream episode Dr. Ghaemi explains why the word “trauma” should be reserved for truly extreme events—historically rooted in Freud’s...
by Nassir Ghaemi | Aug 16, 2025
Uncover the clinical secret of mood temperaments—why hyperthymia, dysthymia and cyclothymia are missed, and how low‑dose mood stabilizers can change outcomes. Dr. Nassir Ghaemi explains that mood temperaments are mild, lifelong mood patterns genetically linked to...
by Nassir Ghaemi | Aug 16, 2025
Is treatment‑resistant depression a myth? Discover why the diagnosis may be flawed and what the data really show. In this live July 4th episode, Dr. Nassir Ghaemi argues that “treatment‑resistant depression” is a misnomer born from an invalid DSM construct—major...
by Nassir Ghaemi | Aug 16, 2025
Long‑term SRI use can trap patients in a hidden withdrawal syndrome—learn why stopping after a year matters. Dr. Nassir Ghaemi explains serotonin withdrawal syndrome, a topic gaining media attention after recent NPR coverage. Because randomized trials of SRIs rarely...